Ubrogepant + Rifampin Interaction
Majorinteraction on record
Description
Strong CYP3A4 inducer resulting in significant reduction in ubrogepant exposure and loss of efficacy. Concomitant use should be avoided.
Mechanism
CYP3A4 induction
Source: NLP:ubrogepant